AlphaFold predicted structure
NAXE · Q8NCW5

Mean pLDDT
86.5/ 100
Confident
288 residues
Confidence breakdown
- Very high(≥ 90)79%
- Confident(70–90)2%
- Low(50–70)1%
- Very low(< 50)18%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
NAD(P)HX epimerase
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Ataxia and cerebellar anomalies - narrow panel
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalInherited white matter disorders
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalWhite matter disorders and cerebral calcification - narrow panel
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalencephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy
mitochondrial disease
inborn mitochondrial metabolism disorder
Decreased total leukocyte count
hereditary disease
atrial fibrillation
hepatocellular carcinoma
Alzheimer disease
neoplasm
neutropenia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
NAD(P)H-hydrate epimerase
Catalyzes the epimerization of the S- and R-forms of NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic or heat-dependent hydration (By similarity) (PubMed:27616477). This is a prerequisite for the S-specific NAD(P)H-hydrate dehydratase to allow the repair of both epimers of NAD(P)HX (By similarity). Accelerates cholesterol efflux from endothelial cells to high-density lipoprotein (HDL) and thereby regulates angiogenesis (PubMed:23719382)
NAXE · Q8NCW5

Mean pLDDT
86.5/ 100
Confident
288 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0